Executive editors: Kenneth R. Chien, Garret A. Fitzgerald, Jeffrey M. Isner, and Judith L. Swain; 8/yr, subscription: $135 (institutions), $60 (personal), New York, NY, Elsevier Science Publishing Co Inc, 1991-.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Trends in Cardiovascular Medicine publishes concise reports on recent developments across a broad range of cardiovascular research.
"Emerging Techniques"—a regular feature—focuses on new diagnostic tools and potential clinical applications. In the journal's first issue, this section contained provocative articles on the role of the polymerase chain reaction for cardiovascular diagnoses and on the feasibility, safety, and utility of percutaneous coronary angioscopy. A "Brief Reviews" section offers short (six-page) articles covering such diverse topics as cell proliferation in atherosclerosis, lipid abnormalities in myocardial cell injury, and the use of molecular mutants and biochemical conjugates in thrombolytic therapy. "Gene Transfer and Cardiovascular Disease" by Elizabeth G. Nabel and Gary J. Nabel is the sort of clearly written distillation of scientific research more often found in the pages of Science or Nature than in a specialized medical journal. (Indeed, two earlier reports on this subject by the same authors did appear in Science
Shah PK, Green EW. Trends in Cardiovascular Medicine. JAMA. 1992;267(1):160. doi:10.1001/jama.1992.03480010168046